| # | Drug | Count |
|---|---|---|
| 0 | MINOXIDIL | 155 |
| 1 | MINOXIDIL FOAM 5% (WOMENS) | 134 |
| 2 | BUPRENORPHINE | 47 |
| 3 | ESTRADIOL | 40 |
| 4 | IMIQUIMOD | 23 |
| 5 | NICOTINE | 22 |
| 6 | METHYLPHENIDATE | 19 |
| 7 | ESTRADIOL GEL 0.1% | 16 |
| 8 | ESTRADIOL TRANSDERMAL | 16 |
| 9 | ESTRADIOL, | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SINECATECHINS | 2 | 0.0370 |
| 1 | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0111 |
| 2 | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | 1 | 0.0109 |
| 3 | MALATHION | 1 | 0.0099 |
| 4 | IMIQUIMOD | 23 | 0.0099 |
| 5 | VYJUVEK | 1 | 0.0076 |
| 6 | TRIFAROTENE | 1 | 0.0055 |
| 7 | MECHLORETHAMINE HYDROCHLORIDE | 12 | 0.0053 |
| 8 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 9 | MINOXIDIL | 155 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Arteriolar Vasodilator [EPC] | 156 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 136 |
| 2 | Estrogen [EPC] | 50 |
| 3 | Partial Opioid Agonist [EPC] | 47 |
| 4 | Benzodiazepine [EPC] | 27 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 22 |
| 7 | Opioid Agonist [EPC] | 21 |
| 8 | Central Nervous System Stimulant [EPC] | 20 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | Arteriolar Vasodilator [EPC] | 156 | 0.0020 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 136 | 0.0013 |
| 3 | Aryl Hydrocarbon Receptor Agonist [EPC] | 2 | 0.0010 |
| 4 | Partial Opioid Agonist [EPC] | 47 | 0.0005 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 22 | 0.0004 |
| 7 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Estrogen [EPC] | 50 | 0.0003 |
| 9 | Nonergot Dopamine Agonist [EPC] | 4 | 0.0003 |